West Pharmaceutical Services Shares Outstanding 2006-2018 | WST

West Pharmaceutical Services shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • West Pharmaceutical Services shares outstanding for the quarter ending September 30, 2018 were 0.076B, a 0.26% decline year-over-year.
  • West Pharmaceutical Services 2017 shares outstanding were 0.076B, a 1.07% increase from 2016.
  • West Pharmaceutical Services 2016 shares outstanding were 0.075B, a 1.63% increase from 2015.
  • West Pharmaceutical Services 2015 shares outstanding were 0.074B, a 1.37% increase from 2014.
West Pharmaceutical Services Annual Shares Outstanding
(Millions of Shares)
2017 76
2016 75
2015 74
2014 73
2013 71
2012 72
2011 74
2010 73
2009 73
2008 72
2007 72
2006 67
2005 65
West Pharmaceutical Services Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 76
Q2 2018 75
Q1 2018 76
Q4 2017 76
Q3 2017 76
Q2 2017 76
Q1 2017 75
Q4 2016 75
Q3 2016 75
Q2 2016 75
Q1 2016 74
Q4 2015 74
Q3 2015 74
Q2 2015 74
Q1 2015 73
Q4 2014 73
Q3 2014 73
Q2 2014 72
Q1 2014 72
Q4 2013 71
Q3 2013 71
Q2 2013 71
Q1 2013 70
Q4 2012 72
Q3 2012 69
Q2 2012 73
Q1 2012 74
Q4 2011 74
Q3 2011 74
Q2 2011 74
Q1 2011 74
Q4 2010 73
Q3 2010 73
Q2 2010 73
Q1 2010 73
Q4 2009 73
Q3 2009 73
Q2 2009 72
Q1 2009 72
Q4 2008 72
Q3 2008 72
Q2 2008 73
Q1 2008 72
Q4 2007 72
Q3 2007 74
Q2 2007 74
Q1 2007 69
Q4 2006 67
Q3 2006 68
Q2 2006 67
Q1 2006 66
Q4 2005 65
Q3 2005 66
Q2 2005 64
Q1 2005 64
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $7.887B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.942B 21.44
McKesson (MCK) United States $25.182B 9.62
AmerisourceBergen (ABC) United States $19.381B 13.82
Align Technology (ALGN) United States $17.596B 44.90
Cardinal Health (CAH) United States $17.075B 11.46
Laboratory Of America Holdings (LH) United States $16.534B 14.97
Henry Schein (HSIC) United States $13.024B 21.41
Cooper (COO) United States $12.484B 22.48
DENTSPLY SIRONA (XRAY) United States $8.036B 16.05
Merit Medical Systems (MMSI) United States $3.169B 37.53
Patterson (PDCO) United States $2.400B 16.87
CONMED (CNMD) United States $1.918B 31.85
STAAR Surgical (STAA) United States $1.808B 186.23
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.528B 0.00
Invacare (IVC) United States $0.210B 0.00
Lifevantage (LFVN) United States $0.170B 24.10
Endologix (ELGX) United States $0.096B 0.00
Pro-Dex (PDEX) United States $0.058B 26.08
Aceto (ACET) United States $0.058B 0.00
Biolase (BIOL) United States $0.026B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00